AU2003295584A1 - Method for continuous, automated blending of solutions from acids and bases - Google Patents

Method for continuous, automated blending of solutions from acids and bases Download PDF

Info

Publication number
AU2003295584A1
AU2003295584A1 AU2003295584A AU2003295584A AU2003295584A1 AU 2003295584 A1 AU2003295584 A1 AU 2003295584A1 AU 2003295584 A AU2003295584 A AU 2003295584A AU 2003295584 A AU2003295584 A AU 2003295584A AU 2003295584 A1 AU2003295584 A1 AU 2003295584A1
Authority
AU
Australia
Prior art keywords
solution
blending
solutions
continuous
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003295584A
Other languages
English (en)
Inventor
Peter G. Brown
Scott P. Fulton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAURUS HSA LLC
Original Assignee
TAURUS HSA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAURUS HSA LLC filed Critical TAURUS HSA LLC
Publication of AU2003295584A1 publication Critical patent/AU2003295584A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003295584A 2002-11-18 2003-11-18 Method for continuous, automated blending of solutions from acids and bases Abandoned AU2003295584A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42731602P 2002-11-18 2002-11-18
US60/427,316 2002-11-18
PCT/US2003/036718 WO2004045540A2 (en) 2002-11-18 2003-11-18 Method for continuous, automated blending of solutions from acids and bases

Publications (1)

Publication Number Publication Date
AU2003295584A1 true AU2003295584A1 (en) 2004-06-15

Family

ID=32326519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003295584A Abandoned AU2003295584A1 (en) 2002-11-18 2003-11-18 Method for continuous, automated blending of solutions from acids and bases

Country Status (6)

Country Link
US (1) US20040102380A1 (enExample)
EP (1) EP1567659A4 (enExample)
JP (1) JP2006513170A (enExample)
AU (1) AU2003295584A1 (enExample)
CA (1) CA2506317A1 (enExample)
WO (1) WO2004045540A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8271139B2 (en) * 2003-10-17 2012-09-18 Asahi Kasei Bioprocess, Inc. Multi-stage accurate blending system and method
US7072742B1 (en) * 2003-10-17 2006-07-04 Technikrom, Inc. Accurate blending module and method
US7515994B2 (en) * 2003-10-17 2009-04-07 Technikrom, Inc. Accurate blending module and method
US20070085989A1 (en) * 2005-06-21 2007-04-19 Nikon Corporation Exposure apparatus and exposure method, maintenance method, and device manufacturing method
US8807164B2 (en) * 2006-08-30 2014-08-19 Semba Biosciences, Inc. Valve module and methods for simulated moving bed chromatography
US7790040B2 (en) 2006-08-30 2010-09-07 Semba Biosciences, Inc. Continuous isocratic affinity chromatography
JP2010505961A (ja) * 2006-10-09 2010-02-25 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
CN102549516A (zh) * 2009-09-25 2012-07-04 通用电气健康护理生物科学股份公司 用于液体混合物的制备的方法和系统
EP2585887B1 (en) * 2010-06-23 2019-01-09 GE Healthcare Bio-Sciences AB Method of preparing liquid mixtures
BR112013009934A2 (pt) 2010-12-07 2016-07-05 Hoffmann La Roche dispositivo para adicionar pelo menos duas soluções de alimentação, aparelho de cultivo celular, uso de um dispositivo e método para obter um polipeptídeo
WO2012090067A1 (en) 2010-12-30 2012-07-05 Lfb Biotechnologies Glycols as pathogen inactivating agents
US10174110B2 (en) 2013-02-13 2019-01-08 Laboratoire Français Du Fractionnement Et Des Biotechnologies Highly galactosylated anti-TNF-α antibodies and uses thereof
WO2014140927A2 (en) 2013-02-13 2014-09-18 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
KR20160029840A (ko) 2013-07-05 2016-03-15 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 친화성 크로마토그래피 매트릭스
WO2015104794A1 (ja) * 2014-01-08 2015-07-16 株式会社日立製作所 試料前処理装置
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
WO2017188917A1 (en) * 2016-04-25 2017-11-02 Safe Foods Corporation Antimicrobial application methods and systems with improved ph monitoring

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1329308A (en) * 1970-09-29 1973-09-05 Dahms H Titration of chloride and bicarbonate in serum
US4555348A (en) * 1984-06-28 1985-11-26 Sybron Chemicals Inc. Liquid buffer system
FR2578982B1 (fr) * 1985-03-18 1987-03-27 Serg Gts Sarl Appareil automatique pour le titrage par pesees de produits liquides et procede de mise en oeuvre d'un tel appareil
US4833233A (en) * 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
US4907892A (en) * 1989-02-02 1990-03-13 Fuller Company Method and apparatus for filling, blending and withdrawing solid particulate material from a vessel
AU6355790A (en) * 1989-08-04 1991-03-11 Peter Grandics An integrated cell culture-protein purification system for the automated production and purification of cell culture products
US5725871A (en) * 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
US5552171A (en) * 1989-10-04 1996-09-03 Micro-Blend, Inc. Method of beverage blending and carbonation
US5823669A (en) * 1991-05-03 1998-10-20 Lolco Packaging Corp. Method for blending diverse blowing agents
US5340210A (en) * 1992-02-25 1994-08-23 Nalco Chemical Company Apparatus for blending chemicals with a reversible multi-speed pump
US5640330A (en) * 1995-04-18 1997-06-17 Ibm Corporation Method for analyzing pH titration data
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
US5639954A (en) * 1995-11-13 1997-06-17 Delco Electronics Corporation Method and apparatus for automatic titration of solder flux
US5996650A (en) * 1996-11-15 1999-12-07 Oden Corporation Net mass liquid filler
US6004508A (en) * 1997-08-01 1999-12-21 The Coca-Cola Company Method and apparatus for super critical treatment of liquids
CA2335613A1 (en) * 1998-06-25 1999-12-29 Lana Janes Ph-indicator based assay for selective enzymes
DE19858892A1 (de) * 1998-12-19 2000-06-21 Merck Patent Gmbh Kontinuierliches Verfahren zur Trennung von Stoffen nach Molekülgröße
US6180335B1 (en) * 1999-09-30 2001-01-30 University Of New Mexico Apparatus for detecting contamination in food products
RU2182505C1 (ru) * 2001-04-18 2002-05-20 Федеральная ассоциация "Двойные технологии" Непрерывный способ детоксикации отравляющих веществ и токсичных химических соединений
BR0210386A (pt) * 2001-06-13 2004-09-14 Taurus Hsa Llc Purificação de albumina de soro humano

Also Published As

Publication number Publication date
CA2506317A1 (en) 2004-06-03
WO2004045540A2 (en) 2004-06-03
WO2004045540A3 (en) 2004-08-19
EP1567659A2 (en) 2005-08-31
EP1567659A4 (en) 2006-08-09
JP2006513170A (ja) 2006-04-20
US20040102380A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
US20040102380A1 (en) Method for continuous, automated blending of solutions from acids and bases
JP2006513170A5 (enExample)
US12024550B2 (en) Bioreactor arrangement and continuous process for producing and capturing a biopolymer
Zhu et al. Industrial production of therapeutic proteins: cell lines, cell culture, and purification
TWI702226B (zh) 治療性蛋白質藥物物質之整合連續製造
US11360085B2 (en) Bacterial endotoxin test for the determination of endotoxins
WO2000068412A1 (en) Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
Padmanabhan et al. The conformation of bound GMPPNP suggests a mechanism for gating the active site of the SRP GTPase
US20220380718A1 (en) Continuous reconstitution of process materials from solids
US20120070872A1 (en) Use of erythromycin as a selective antimicrobial agent in the production of alcohols
CN111676184A (zh) 一种由补料培养基共混的基础培养基及其制备方法和应用
Vikram et al. Recent advancements in continuous crystallization of proteins
Mannall et al. Ultra scale‐down of protein refold screening in microwells: challenges, solutions and application
JP2024020456A (ja) 一体型かつ連続した組換えタンパク質の製造
JP2006504076A (ja) 生体分子の安定化のための組成物およびプロセス
Irfan Carbon dioxide control in bioreactors and the application of principal component analysis to cell culture process data
CN118166053B (zh) 一种制备低o-糖基化水平的重组人白蛋白的方法
Schmidt Process intensification in biomanufacturing driven by advances in single use technologies
Hoeks et al. BPMSS–Lonza's Biopharmaceutical Small Scale Plant Started cGMP Manufacturing in September 2004
EA044422B1 (ru) Способ очистки ифр-1
Tolbert et al. Application of large scale perfusion systems for pharmaceutical production from mammalian cells
CN120988979A (zh) 一种胚胎培养液及其制备方法和应用
Zheng Process development for downstream processing of human growth hormone and its antagonist
JP2020507336A5 (enExample)

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period